The global kidney and pancreas transplant market is anticipated to grow at a significant CAGR of 9.7% during the forecast period (2021-2028). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace this is anticipated to positively impact significant market growth. For instance-
April 2021- The US FDA has approved Farxiga oral tablets which reduce the risk of kidney function decline, kidney failure, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney diseases. The FDA granted Farxiga to Astra Zeneca.
A full report of Kidney and Pancreas Transplant Market is available at: https://www.omrglobal.com/industry-reports/global-kidney-and-pancreas-transplant-market
July 2021- The FDA approved finerenone, a nonsteroidal mineralocorticoid receptor antagonist for the treatment of patients with chronic kidney disease(CKD9, associated with type 2 diabetes. The drug works to slow the chronic kidney disease progression and assists in reducing the risk of kidney failure, heart attack, or cardiovascular death in patients with CKD associated with T2D.
December 2021- The US FDA has cleared the ovarian cancer drug Lynparza to treat advanced pancreatic cancer. This treatment assists to treat the pancreas and whose tumors did not grow after at least 16 weeks of chemotherapy.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/global-kidney-and-pancreas-transplant-market
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2021-2028
- Segment Covered- by sources,by treatment, by end user
- Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
- Competitive Landscape- are AbbVie Inc, Medtronic plc, Novartis AG, Pfizer Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Luminex, Organ Recovery Systems Inc., and Organogenesis, and others
Key questions addressed by the report
- What is the market growth rate?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Kidney and Pancreas Transplant Market– Segmentation
By Sources
- Living Donors
- Deceased Donors
By Treatment
- Analgesic
- Immunosuppressant
- Others
By End User
- Hospitals
- Transplant Centers
- Others
